Castile and Leon has suspended AstraZeneca's vaccination in cauterity

This is an automated machine translation of an article published by Business Insider in a different language. Machine translations can generate errors or inaccuracies; we will continue the work to improve these translations. You can find the original version here.

Castilla y León has suspended on a precautionary basis this Wednesday the vaccination with AstraZeneca until the decision of the European Medicines Agency (EMA) that this afternoon will be announced in relation to a possible link between this drug and the risk of thrombi.

According to the newspaper El Norte de Castilla, the suspension of the vaccine was announced over the loudspeakers this morning to those who had been summoned to the Miguel Delibes Auditorium in Valladolid to be vaccinated this morning with this dose.

Subsequently, the Board has issued a statement in which it points out that “the precautionary measure is adopted while awaiting the safety report” that is expected to be prepared by the Pharmacovigilance Risk Assessment Committee of the EMA” and “the decisions that may be adopted soon in relation to this issue by the executive bodies of the European Union and the National Health System”.

In this respect, the Regional Minister of Health, Verónica Casado, has supported the suspension in “the news we received this morning about the possible change of decision by the EMA to prioritize patient safety”, according to statements made by El Pais.

According to the minister, the temporary halt has been adopted “until we know the opinion of the EMA, the position of the vaccine commission of the ministry and to have a common position in the inter-territorial council”.

Although she recognized that the “adverse effects are minimal”, she assured that “until we have all the information, we have decided to be cautious”.

The EMA will review the ethical standards of the trials of the Russian vaccine Sputnik

The decision of the Junta de Castilla y León to halt the vaccination with AstraZeneca comes after the head of vaccine strategy at the EMA Marco Cavaleri declared in a personal capacity in an interview with the Italian newspaper Il Messaggero published yesterday that there may be a “link” between the thrombi detected in some vaccinated patients and the drug.

“Now we can say it, it is clear that there is a link with the vaccine. What causes this reaction, however, we still do not know (…) In short, in the next few hours, we will say that there is a link, but we still have to understand how it happens,” Cavaleri acknowledged in statements reported by El Norte de Castilla.

This is the second time that vaccination with AstraZeneca has been suspended in the community. Several European countries, including Spain, paralyzed vaccination with the AstraZeneca injection for 15 days after several cases of thrombi were detected in people who had been vaccinated with this dose in mid-March.

In our country, the AstraZeneca vaccine is the drug being used to vaccinate children under 65 years of age and groups such as teachers and police officers.

Source: Read Full Article